Contact

Accessing US markets – Nasdaq and FDA approval

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara.Â In this episode Matt will be joined by Opthea CEO & Managing Director Dr Megan Baldwin and Phamaxis CEO Gary Phillips.

Recent Podcasts

BioBullets: The Great Dispersion

BioBullets: The Aduhelm FDA approval controversy

Introduction to Horizon 3

Accessing US markets – Nasdaq and FDA approval

BioBullets: The Great Dispersion

BioBullets: The Aduhelm FDA approval controversy

Introduction to Horizon 3

Topical investment strategies in biotech

Accessing US markets – Nasdaq and FDA approval

Horizon 3 Biotech Fund and what drives investment decisions

Matt talks to Dimerix & Crucible Investments

Healthcare investment and the outlook for 2021

Introduction to Horizon3

Contacts

About

Help

Terms & Privacy

Contact